Literature DB >> 12210832

Alterations in matrix metalloproteinase-9 levels and tissue inhibitor of matrix metalloproteinases-1 expression in a transforming growth factor-beta transgenic model of hydrocephalus.

Jennifer Zechel1, Harsh Gohil, W David Lust, Alan Cohen.   

Abstract

The development of spontaneous hydrocephalus in mouse models resulting from the overexpression of transforming growth factor-beta (TGFbeta-1) has been previously described, although the mechanism by which this occurs remains obscure. It has been previously demonstrated that increased expression of TGFbeta has consequences for the levels of matrix metalloproteinases (MMPs) and their specific inhibitors (tissue inhibitors of MMPs, or TIMPs). These remodeling proteins play an important role in extracellular matrix (ECM) maintenance through degradation and deposition of ECM components. The present study investigated the relationship between elevated levels of TGFbeta-1, the ECM modulators TIMP-1 and MMP-9, and development of hydrocephalus in the neonatal mouse. In newborn pups, TIMP-1 mRNA levels were equal between animals expressing the TGFbeta-1 transgene and littermates without the transgene. However, immunohistochemistry of littermate pups shows that the distribution of TIMP-1 was changed from homogeneous with large punctate concentrations of signal to uniform, dense staining in hydrocephalic animals carrying the TGFbeta-1 transgene. The mRNA levels of MMP-9 were decreased in the transgenic animals, as were the activity levels MMP-9. These results suggest that the remodeling protein MMP-9 and its specific inhibitor, TIMP-1, may contribute to the spontaneous development of hydrocephalus in this transgenic model by altering the ECM environment. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12210832     DOI: 10.1002/jnr.10326

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  13 in total

1.  Increased Peripheral CD137 Expression in a Mouse Model of Permanent Focal Cerebral Ischemia.

Authors:  Xiao-Qing Li; Yang-Yang Wang; Ting-Ting Yang; Yi-Ning Qian; He Yin; Shan-Shan Zhong; Rong A; Yang He; Bao-Lei Xu; Guang-Zhi Liu
Journal:  Cell Mol Neurobiol       Date:  2019-02-18       Impact factor: 5.046

Review 2.  Transforming growth factor-β1 and diabetic nephropathy.

Authors:  Albert S Chang; Catherine K Hathaway; Oliver Smithies; Masao Kakoki
Journal:  Am J Physiol Renal Physiol       Date:  2015-12-30

3.  TGF-betal transgenic mouse model of thoracic irradiation: modulation of MMP-2 and MMP-9 in the lung tissue.

Authors:  Kunyu Yang; Li Liu; Tao Zhang; Gang Wu; Claudia Ruebe; Christian Ruebe; Yu Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2006

4.  Nuclear factor I X deficiency causes brain malformation and severe skeletal defects.

Authors:  Katrin Driller; Axel Pagenstecher; Markus Uhl; Heymut Omran; Ansgar Berlis; Albert Gründer; Albrecht E Sippel
Journal:  Mol Cell Biol       Date:  2007-05       Impact factor: 4.272

5.  Diffusion-weighted magnetic resonance imaging reversal by gene knockdown of matrix metalloproteinase-9 activities in live animal brains.

Authors:  Christina H Liu; Zerong You; Charng-Ming Liu; Young R Kim; Michael J Whalen; Bruce R Rosen; Philip K Liu
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

Review 6.  Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system.

Authors:  Jessica Gardner; Anuja Ghorpade
Journal:  J Neurosci Res       Date:  2003-12-15       Impact factor: 4.164

7.  ATXN1 protein family and CIC regulate extracellular matrix remodeling and lung alveolarization.

Authors:  Yoontae Lee; John D Fryer; Hyojin Kang; Juan Crespo-Barreto; Aaron B Bowman; Yan Gao; Juliette J Kahle; Jeong Soo Hong; Farrah Kheradmand; Harry T Orr; Milton J Finegold; Huda Y Zoghbi
Journal:  Dev Cell       Date:  2011-10-18       Impact factor: 12.270

Review 8.  Genetics of human hydrocephalus.

Authors:  Jun Zhang; Michael A Williams; Daniele Rigamonti
Journal:  J Neurol       Date:  2006-06-13       Impact factor: 4.849

Review 9.  Nonsurgical therapy for hydrocephalus: a comprehensive and critical review.

Authors:  Marc R Del Bigio; Domenico L Di Curzio
Journal:  Fluids Barriers CNS       Date:  2016-02-05

10.  Intranasal delivery of transforming growth factor-beta1 in mice after stroke reduces infarct volume and increases neurogenesis in the subventricular zone.

Authors:  Minmin Ma; Yuping Ma; Xueming Yi; Ruibing Guo; Wusheng Zhu; Xinying Fan; Gelin Xu; William H Frey; Xinfeng Liu
Journal:  BMC Neurosci       Date:  2008-12-10       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.